Optibiotix Health Share Discussion Threads

[spike_1] 24/1/2017 07:23

Difficult to know quite how important this is. The good news is that they have clearly done trials on a number of species/strands, and will be able to demonstrate they have taken them to the point where they are robust enough and cheap enough to be commercially viable.

Unfortunately - as usual - it is difficult to put a commercial value on it in the near term?

Best wishes - Mike

[judijudi] 24/1/2017 07:17

Interesting :)

[someuwin] 24/1/2017 07:09

RNS Number : 8917U
OptiBiotix Health PLC
24 January 2017


OptiBiotix Health plc

("OptiBiotix" or the "Company")



Presentation of research at Microbiome R&D and Business Collaboration: Asia



OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it will be presenting research data on its microbiome modulators at the Microbiome R&D and Business Collaboration Congress: Asia, in Hong Kong on the 1-2 March 2017. The conference brings together experts in all areas of microbiome research and is recognised around the world as one of theleading conferences for bringing together pharma, biotech, academic institutions and investors who are looking to develop and progress ground-breaking microbiome research into next generation products through partnering.



OptiBiotix's conference abstract and presentation covers research which demonstrates the company's ability to create designer ingredients which can modify an individual's microbiome. These studies suggest commercial potential for:-



i. The development of species or genera specific prebiotics which can selectively enhance the growth and health benefits of existing probiotic products. This new product concept, called an OptiBiotic®, has the potential to enhance probiotic health benefits and provide product differentiation in the probiotic market, a market forecast to be worth more than $46.5bn by 2020 (Markets and Markets).

ii. Designer ingredients which can modify an individual's current microbiome to improve health. These ingredients are heat resistant and stable during processing, which creates the opportunity to incorporate low cost, safe, ingredients which modulate specific elements of the microbiome in a wide range of food products.



Commenting, Stephen O'Hara, CEO of OptiBiotix said: "The ability to create designer ingredients which can modify an individual's microbiome to improve health places OptiBiotix at the forefront of global microbiome research and product development. I believe we are fast approaching the next stage in the development of the microbiome in healthcare, where scientists have the ability to precision engineer components of the microbiome to prevent, manage and treat many of today's chronic lifestyle diseases."

[parob] 23/1/2017 20:59

British Bulls signal:



Signal Update

Our system’s recommendation today is to STAY LONG. The previous BUY signal was issued on 06/01/2017, 17 days ago, when the stock price was 62.5723. Since then OPTI.L has risen by +25.06%.

Market Outlook

The bulls are in full control. The negative sentiment that led to the last bearish pattern has evaporated. Besides, the signal is suggesting to STAY LONG. It is best to follow the signal and continue to hold this security.

[joyjoy13] 23/1/2017 19:54

Wow, just logged on!
Fantastic.
Few pennies a day will do me nicely.
Good luck all

[elrico] 23/1/2017 19:33

A little birdy told me Max and his GoFigure team invade Iceland tomorrow armed with goodies for their largest pharma outlets where there will be hands-on promo tour.

That little birdies was me...yes, I speak to myself in the mirror. Joking apart, it's true.

[judijudi] 23/1/2017 19:32

Owen,
Pure genius! :)

[owenmo] 23/1/2017 19:30

My sentiments too Judi.

[judijudi] 23/1/2017 19:24

Rocket Science from Diamond
Great news coming and some exciting announcements
Never!!! :)

[1bokke] 23/1/2017 19:18

Diamond, based on your post I hope you haven't bought any shares today...

[elrico] 23/1/2017 19:15

Jimbo - given OPTI overheads should remain pretty constant due the business model, the profit margins of IP/strains is high 90s, near 100 I think SOH stated, the royalties on products are typically 7-15%, so pretty much straight to the bottomline. OPTI could effectively be profitable as whole just off the slimbiome deals already signed by YE 2017, being my personal opinion.

[adorling] 23/1/2017 18:54

Df - is this insider info or have you been reading your TATA tea leaves?

[colinzeal] 23/1/2017 18:50

Any ideas when?

[jimbobjames2002] 23/1/2017 17:49

Does anyone know or would like to hazard a guess at what kind of profit margin there is on the GoFigure shakes and bars? I'd imagine they have a pretty decent markup given the retail price.

Would also be interesting to know/approximate how many units they have sold so far with very little promotion.

[diamond fibre] 23/1/2017 17:36

If you think this price rise comes on imminent news, you are correct, I know for fact and with out wanting to get any one in trouble,great news coming and some exciting announcements as well.

[parob] 23/1/2017 17:26

The highest volume in 3 months today and the share continues to climb. Lots of catching up to do after being held back for a year by the seller(s).With no overhang, I am more than happy with these daily 2/3p increases.

[judijudi] 23/1/2017 17:17

I think we have let them have enough today
Be nice for buyers to take control again in the morning

[john henry] 23/1/2017 16:59

Kipper large sellers have completed, no overhang, buyers hence the rise.

[1bokke] 23/1/2017 16:23

Elrico I agree, I think a few people have remembered the 90p high we had before falling back on no news and have sold this afternoon in anticipation of the same. Personally I think 2017 is a very different prospect to 2016 and I know a profit is a profit and all that but given what we are expecting to hear I think it's very premature to even think about selling in q1.

[elrico] 23/1/2017 14:55

Kipper - In my experience there is a 12 month disconnect with the market correctly valuing and catching up with a company's progress, in OPTI's case, there is still some catching up because it is difficult to understand new science.

MM games have begun, I said I expected there to be a rise and a fall back as MM attempt to stop weak holders out. New on any front Tuesday could seriously test the resistance and on to new highs before spring product launches. I wouldn't want to be out now or take profits at these levels. AIM is not the problem, it is investor logic that often proves illogical...IMHO.

[kipper1960] 23/1/2017 14:39

Interesting that many posters on here - including myself - felt the only way to halt the share price drift last year was some hard commercial news. Well, this year there have still been no hard commercial deal announcements, just a couple of jam tomorrow announcements of new senior appointments - and the share price has gone up 30%! I can only conclude that the market has taken this long to understand what we have known all along about OPTI.
Therefore,difficult to predict what will happen when these commercial deals, partnerships and de-merger are finally announced. Logic says massive share price growth, but AIM has often proved to be illogical .

[scotty1] 23/1/2017 11:41

MMs now trying it on to get some more sellers,back up soon i would imagine ;)))